title: SFPO and ESOP recommendations for the practical stability of anticancer drugs: an update.
abstract: The recommendations for the practical stability of anticancer drugs published in 2010 by the French Society of Hospital Pharmacists (SFPO) and the European Society of Oncology Pharmacists (ESOP) have been updated. Ten new molecules have been included (asparaginase, azacitidine, bevacizumab, clofarabine, eribuline mesylate, folinate sodium, levofolinate calcium, nelarabine, rituximab, temsirolimus).
authors.affiliation: Pharmacy, university hospital, rue du Morvan, 54511 Vandœuvre, France. Electronic address: j.vigneron@chu-nancy.fr.
authors.forename: J
authors.initials: J
authors.lastname: Vigneron
authors.forename: A
authors.initials: A
authors.lastname: Astier
authors.forename: R
authors.initials: R
authors.lastname: Trittler
authors.forename: J D
authors.initials: JD
authors.lastname: Hecq
authors.forename: M
authors.initials: M
authors.lastname: Daouphars
authors.forename: I
authors.initials: I
authors.lastname: Larsson
authors.forename: B
authors.initials: B
authors.lastname: Pourroy
authors.forename: F
authors.initials: F
authors.lastname: Pinguet
mesh_terms: D000911:Antibodies, Monoclonal / Q000032:analysis / Q000737:chemistry; D000970:Antineoplastic Agents / Q000737:chemistry* / Q000592:standards*; D017024:Chemotherapy, Adjuvant; D004355:Drug Stability; D006801:Humans; D008495:Medical Oncology; D010595:Pharmacists; D010607:Pharmacy Service, Hospital; D012957:Societies, Pharmaceutical
chemical_list: D000911:Antibodies, Monoclonal; D000970:Antineoplastic Agents
keywords: Anticancer drugs; Anticancéreux; Anticorps monoclonaux; Dose banding; Monoclonal antibodies; Stabilis(®); Stability; Stabilité